RetractedArticlePharmaceutics2021

Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation.

Shiwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.